SK bioscience to transfer technology for strengthening vaccine manufacturing in Thailand

South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...

July 6, 2023 | Thursday | News
Japan approves updated indication for GSK's Shingrix vaccine

British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...

June 28, 2023 | Wednesday | News
Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...

June 28, 2023 | Wednesday | News
International Vaccine Institute inks new agreement with Seoul National University

The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...

June 21, 2023 | Wednesday | News
Vaxxas opens manufacturing facility in Australia to produce needle-free vaccine patch

Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...

June 19, 2023 | Monday | News
Korea-Africa establish new partnership for vaccine R&D and biomanufacturing training

South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...

June 14, 2023 | Wednesday | News
mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers: Merck study

According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...

June 1, 2023 | Thursday | News
SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...

May 31, 2023 | Wednesday | News
Devising a viable global strategy to combat Cholera

For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...

May 31, 2023 | Wednesday | Opinion
Korea's International Vaccine Institute establishes Joint Research Institution in China

South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...

May 23, 2023 | Tuesday | News
China approves two COVID-19 vaccine trials against most recent circulating XBB variants

Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...

May 22, 2023 | Monday | News
World’s first and only oral cholera vaccine in LDPE unidose pack launches in India

TechInvention Lifecare in India, has partnered with Eubiologics Co. in  South Korea,  to  launch Euv...

May 12, 2023 | Friday | News
International partnership supports vaccine research to prevent future outbreaks

Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...

May 8, 2023 | Monday | News
Korea begins clinical development of new low-cost oral cholera vaccine in capsule form

The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...

May 1, 2023 | Monday | News
US FDA approves Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for children

American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...

April 28, 2023 | Friday | News
Survey: One-third of COVID-19 vulnerable groups avoid booster shots

The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...

April 25, 2023 | Tuesday | Company results
Singapore unveils new approach to aid pneumococcal vaccine development

Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the caps...

April 20, 2023 | Thursday | News
BioMinhai and Biotis to promote development of vaccine industry in Indonesia

Beijing Minhai Biotechnology Co., (BioMinhai), a wholly-owned subsidiary of China-based Shenzhen Kangtai Biological Prod...

April 8, 2023 | Saturday | News